GL
REGN icon

GLG LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

GLG LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,327
Closed -$2.83M – 495
2017
Q3 		$2.83M Sell
6,327
-589
-9% -$280K 0.18% 144
2017
Q2 		$3.4M Buy
6,916
+1,987
+40% +$870K 0.21% 137
2017
Q1 		$1.91M Buy
+4,929
New +$1.83M 0.11% 232
2016
Q4 		– Sell
-4,180
Closed -$1.68M – 537
2016
Q3 		$1.68M Sell
4,180
-362
-8% -$145K 0.12% 194
2016
Q2 		$1.59M Sell
4,542
-750
-14% -$289K 0.12% 193
2016
Q1 		$1.91M Sell
5,292
-834
-14% -$344K 0.12% 201
2015
Q4 		$3.33M Buy
6,126
+5,201
+562% +$2.82M 0.2% 137
2015
Q3 		$430K Sell
925
-13
-1% -$6.98K 0.01% 503
2015
Q2 		$479K Sell
938
-104
-10% -$50.8K 0.01% 566
2015
Q1 		$470K Buy
1,042
+796
+324% +$337K 0.01% 539
2014
Q4 		$101K Sell
246
-23,500
-99% -$9.24M ﹤0.01% 592
2014
Q3 		$8.56M Sell
23,746
-98
-0.4% -$32.8K 0.23% 134
2014
Q2 		$6.74M Buy
23,844
+19,400
+437% +$5.75M 0.2% 152
2014
Q1 		$1.33M Buy
+4,444
New +$1.37M 0.04% 414

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

GLG LLC's REGN Position: Q4 2017 in Review

GLG LLC sold out of Regeneron Pharmaceuticals (REGN) in Q4 2017, closing a stake of 6,327 shares — an estimated $2.83M sold.

GLG LLC first reported a position in REGN in Q1 2014 and held it in 14 quarters. The position peaked at $8.56M in Q3 2014. 638 funds tracked by Wall St. Rank hold REGN as of Q4 2017.

  • GLG LLC reported no remaining Regeneron Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • GLG LLC sold 6,327 Regeneron Pharmaceuticals shares in Q4 2017, an estimated $2.83M.
  • GLG LLC first reported a position in Regeneron Pharmaceuticals in Q1 2014 and held it in 14 quarters.
  • GLG LLC's Regeneron Pharmaceuticals position peaked at $8.56M in Q3 2014.
  • 638 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.